Prevention of premature ovulation in patients undergoing a controlled ovarian stimulation followed by oocyte pick-up & assisted reproductive techniques.
SC 0.25 mg once daily at 24 hr intervals in the morning or evening. Morning dose: Commence on day 5 or 6 of ovarian stimulation (approx 96-120 hr after start of ovarian stimulation) w/ urinary or recombinant gonadotropins. Continue throughout the gonadotropin treatment period including the day of ovulation induction. Evening dose: Commence on day 5 of ovarian stimulation (approx 96-108 hr after start of ovarian stimulation) w/ urinary or recombinant gonadotropins. Continue throughout the gonadotropin treatment period until the evening prior to the day of ovulation induction.
Possible allergic/pseudoallergic reactions including life-threatening anaphylaxis w/ the 1st dose. Women w/ signs & symptoms of active allergic conditions or known history of allergic predisposition; do not advise Cetrotide in women w/ severe allergic conditions. Possible ovarian hyperstimulation syndrome (OHSS). Administration during repeated ovarian stimulation procedure. Congenital anomalies. Hepatic & renal impairment. No relevant indication for use in childn & elderly.
Sign Out
